Get my own profile
Public access
View all10 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Diane J. BurgessUniversity of Connecticut Board of Trustees Distinguished Professor of PharmaceuticsVerified email at uconn.edu
- Yan WangU.S. Food and Drug AdministrationVerified email at fda.hhs.gov
- Yuan ZouFDA / CDER / OGDVerified email at fda.hhs.gov
- Ruifeng WangUniversity of ConnecticutVerified email at uconn.edu
- Bryan NewmanFood and Drug AdministrationVerified email at fda.hhs.gov
- Jie ShenAssociate Professor at Northeastern UniversityVerified email at northeastern.edu
- Suraj FansePhD graduate student in Pharmaceutics at University of ConnecticutVerified email at uconn.edu
- Bin QinFDA/CDER/OGDVerified email at fda.hhs.gov
- Darby KozakUS FDA / CDER / OGDVerified email at fda.hhs.gov
- Shawn ZhangDigiM Solution LLCVerified email at digimsolution.com
- Xiaoming XuOffice of Pharmaceutical Quality Research, US FDAVerified email at fda.hhs.gov
- Michail KastelloriziosAssistant Professor of PharmaceuticsVerified email at unthsc.edu
- Min Sung SuhFood and Drug AdministrationVerified email at uconn.edu
- René HolmUniversity of Southern DenmarkVerified email at sdu.dk
- Jia HeUniversity of Connecticut; Amgen Inc.Verified email at amgen.com
Follow
Quanying Bao
Alexion, AstraZeneca Rare Disease; Boehringer Ingelheim; UConn; Novartis
Verified email at alexion.com